IRIS
REZZA, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.289
EU - Europa 5.306
NA - Nord America 3.542
SA - Sud America 1.032
AF - Africa 152
OC - Oceania 15
Totale 16.336
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 3.668
US - Stati Uniti d'America 3.367
SG - Singapore 2.781
CN - Cina 1.680
BR - Brasile 876
HK - Hong Kong 856
VN - Vietnam 463
IT - Italia 425
FR - Francia 340
DE - Germania 233
GB - Regno Unito 172
AT - Austria 90
IN - India 82
CA - Canada 81
FI - Finlandia 75
BD - Bangladesh 65
NL - Olanda 63
MX - Messico 62
SE - Svezia 59
AR - Argentina 58
PL - Polonia 55
TR - Turchia 51
IQ - Iraq 48
ZA - Sudafrica 45
JP - Giappone 38
PK - Pakistan 38
ES - Italia 32
ID - Indonesia 26
SA - Arabia Saudita 26
EC - Ecuador 25
AE - Emirati Arabi Uniti 19
CO - Colombia 18
CZ - Repubblica Ceca 18
LT - Lituania 17
KE - Kenya 15
PH - Filippine 15
PY - Paraguay 15
AU - Australia 14
MA - Marocco 14
UZ - Uzbekistan 14
DZ - Algeria 13
NG - Nigeria 13
UA - Ucraina 13
VE - Venezuela 13
EG - Egitto 12
CL - Cile 11
JO - Giordania 11
TN - Tunisia 10
TW - Taiwan 10
JM - Giamaica 9
IL - Israele 8
CH - Svizzera 7
MY - Malesia 7
BE - Belgio 6
BO - Bolivia 6
CR - Costa Rica 6
IE - Irlanda 6
KG - Kirghizistan 6
UY - Uruguay 6
AZ - Azerbaigian 5
GR - Grecia 5
IR - Iran 5
KR - Corea 5
KZ - Kazakistan 5
NP - Nepal 5
TH - Thailandia 5
GH - Ghana 4
SN - Senegal 4
UG - Uganda 4
AL - Albania 3
CU - Cuba 3
ET - Etiopia 3
HR - Croazia 3
HU - Ungheria 3
LB - Libano 3
OM - Oman 3
PE - Perù 3
RO - Romania 3
RS - Serbia 3
AO - Angola 2
BB - Barbados 2
BG - Bulgaria 2
BZ - Belize 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
PA - Panama 2
PS - Palestinian Territory 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
DM - Dominica 1
GA - Gabon 1
KH - Cambogia 1
LS - Lesotho 1
LV - Lettonia 1
Totale 16.321
Salva come PNG Salva come JPEG
Città #
Singapore 1.383
San Jose 895
Hong Kong 843
Moscow 807
Ashburn 646
Dallas 570
Shanghai 406
Hefei 331
Lauterbourg 287
Ho Chi Minh City 181
Beijing 140
Hanoi 111
São Paulo 86
Los Angeles 85
New York 72
Nuremberg 69
Brooklyn 54
Munich 51
Milan 49
Santa Clara 49
Warsaw 49
Boardman 47
Orem 46
Rome 46
Lappeenranta 41
Vienna 39
Council Bluffs 38
Tokyo 34
Montreal 33
Stockholm 31
Atlanta 30
Denver 30
Kassel 30
Rio de Janeiro 30
Assago 26
Guangzhou 26
London 26
Chennai 25
Chicago 25
Johannesburg 25
Amsterdam 24
Mexico City 24
Ankara 23
Da Nang 22
Boston 21
Turku 21
Hangzhou 19
Phoenix 19
Poplar 19
Baghdad 17
Belo Horizonte 17
Curitiba 17
Haiphong 16
Lahore 16
Seattle 16
Wolfhagen 16
Brno 15
Frankfurt am Main 15
Manchester 15
Romagnano Sesia 15
Toronto 15
Mumbai 13
Goiânia 12
Helsinki 12
Jeddah 12
Nairobi 12
San Francisco 12
Amman 11
Cesano Boscone 11
Guayaquil 11
Porto Alegre 11
Shenzhen 11
Tashkent 11
Buffalo 10
Salvador 10
Buenos Aires 9
Cairo 9
Cape Town 9
Casoria 9
City of London 9
Erbil 9
Princeton 9
Riyadh 9
Washington 9
Brasília 8
Changsha 8
Charlotte 8
Houston 8
Lawrence 8
Sydney 8
São Bernardo do Campo 8
Xi'an 8
Abu Dhabi 7
Biên Hòa 7
Campinas 7
Can Tho 7
Guarulhos 7
Jakarta 7
Manaus 7
Pittsburgh 7
Totale 8.534
Salva come PNG Salva come JPEG
Nome #
Climate change, human migration and health nexus: what do we know about public health implications on a global scale? 165
Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: Retrospective cohort study 129
The new Italian National Immunization Technical Advisory Group (NITAG) and its commitment to endorse a new efficient National Immunization Plan in COVID-19 times 129
2) HERV-H per l'uso come marcatore molecolare del Disturbo dello Spettro Autistico e relativo metodo diagnostico in vitro, kit diagnostico e usi medici (2012).GAUDI S F 116
AIDS and injecting drug use: survival determinants in the highly active antiretroviral therapy era 110
Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a retrospective matched cohort study 106
COVID-19 vaccines: where we stand and challenges ahead 101
Aedes albopictus and the reemergence of Dengue 101
L'accesso alle cure della persona straniera: indicazioni operative 99
A SARS-CoV-2 Outbreak Among Nursing Home Residents Vaccinated with a Booster Dose of mRNA COVID-19 Vaccine 99
Adult vaccination as the cornerstone of successful ageing: the case of herpes zoster vaccination. A European Interdisciplinary Council on Ageing (EICA) expert focus group 97
Protection against severe COVID-19 after second booster dose of adapted bivalent (original/Omicron BA.4-5) mRNA vaccine in persons ≥ 60 years, by time since infection, Italy, 12 September to 11 December 2022 97
A Caprine Herpesvirus 1 Vaccine Adjuvanted with MF59 (TM) Protects against Vaginal Infection and Interferes with the Establishment of Latency in Goats 94
A community-acquired Legionnaires' disease outbreak caused by Legionella pneumophila serogroup 2: An uncommon event, Italy, August to October 2018 94
Tracking the progressive spread of the SARS-CoV-2 Omicron variant in Italy, December 2021 to January 2022 93
Vaccinating in Different Settings: Best Practices from Italian Regions 91
An outbreak of Q fever in Bulgaria 90
Relative effectiveness of bivalent Original/Omicron BA.4-5 mRNA vaccine in preventing severe COVID-19 in persons 60 years and above during SARS-CoV-2 Omicron XBB.1.5 and other XBB sublineages circulation, Italy, April to June 2023 89
A vaccine against Ebola: Problems and opportunities 89
Effectiveness of an mRNA vaccine booster dose against SARS-CoV-2 infection and severe COVID-19 in persons aged ≥60 years and other high-risk groups during predominant circulation of the delta variant in Italy, 19 July to 12 December 2021 88
Acute respiratory distress syndrome due to influenza virus A/H1N1v in a patient with HIV/HCV co-infection 88
Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy: A retrospective matched cohort study 88
La storia dell' infezione da HIV in Italia: epidemiologia ,trend e problemi del sommerso 88
A desk review on institutional and non-institutional organizations active in the field of migrant's health in the WHO European Region 87
Estimated Effectiveness of a Primary Cycle of Protein Recombinant Vaccine NVX-CoV2373 Against COVID-19 87
Analysis of Genomic Characteristics of SARS-CoV-2 in Italy, 29 January to 27 March 2020 86
Monitoring medicine prescriptions before, during and after pregnancy in Italy 85
SARS-CoV-2 transmission in the lombardy region: The increase of household contagion and its implication for containment measures 85
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 85
Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5–11 years in Italy: a retrospective analysis of January–April, 2022 83
An outbreak of severe invasive meningococcal disease due to a capsular switched Neisseria meningitidis hypervirulent strain B:cc11 83
A large food-borne outbreak of campylobacteriosis in kindergartens and primary schools in Pescara, Italy, May–June 2018 83
Diagnosis of Imported Dengue and Zika Virus Infections in Italy from November 2015 to November 2022: Laboratory Surveillance Data from a National Reference Laboratory 82
A large ongoing outbreak of hepatitis A predominantly affecting young males in Lazio, Italy; August 2016 - March 2017 81
An autochthonous case of Zika due to possible sexual transmission, Florence, Italy, 2014 81
Estimating SARS-CoV-2 infections and associated changes in COVID-19 severity and fatality 81
An atypical case of multifocal infantile haemangioma in a child after Highly Active Antiretroviral Therapy (HAART) during pregnancy 79
The law on compulsory vaccination in italy: An update 2 years after the introduction 78
An early start of west nile virus seasonal transmission: The added value of one heath surveillance in detecting early circulation and triggering timely response in Italy, June to July 2018 78
Evaluation of HIV transmission clusters among natives and foreigners living in Italy 77
Attitudes and practices of dentists treating patients infected with human immunodeficiency virus in the era of highly active antiretroviral therapy 77
Psychiatric disorders among hospitalized patients deceased with COVID-19 in Italy 76
Vaccine coverage and determinants of incomplete vaccination in children aged 12-23 months in Dschang, West Region, Cameroon: a cross-sectional survey during a polio outbreak 72
Childhood Immunisation Coverage during the COVID-19 Epidemic in Italy 72
Acute Flaccid Paralysis surveillance in Bosnia and Herzegovina: recent isolation of two Sabin like type 2 poliovirus 72
AIDS, Drug Misuse and the Global Crisis. In: AIDS and Drug Misuse: the challenge for policy and practice in 1990s. 72
Clinical characteristics of individuals with Down syndrome deceased with CoVID-19 in Italy—A case series 69
COVID-19 Vaccines: Current and Future Perspectives 67
O’nyong-nyong fever: a neglected mosquito-borne viral disease 67
Are vaccine shortages a relevant public health issue in Europe? Results from a survey conducted in the framework of the EU Joint Action on Vaccination 66
Increasing Number of Cases Due to Candida auris in North Italy, July 2019–December 2022 65
Gene flow and Bayesian phylogeography of serogroup C meningococci circulating in Italy 65
Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy 65
Whole genome and phylogenetic analysis of two SARSCoV-2 strains isolated in Italy in January and February 2020: Additional clues on multiple introductions and further circulation in Europe 65
Vaccination of 50+ adults to promote healthy ageing in Europe: The way forward 64
Bayesian Phylogeography of Crimean-Congo Hemorrhagic Fever Virus in Europe 64
The common European mosquitoes Culex pipiens and Aedes albopictus are unable to transmit SARS-CoV-2 after a natural-mimicking challenge with infected blood 63
Rapid increase in neuroinvasive West Nile virus infections in humans, Italy, July 2022 63
The impact of SARS-CoV-2 infection in patients with cystic fibrosis undergoing CFTR channel modulators treatment: a literature review 63
LASSO Regression Modeling on Prediction of Medical Terms among Seafarers’ Health Documents Using Tidy Text Mining 63
Prevalence of SARS-CoV-2 infection in Italian pediatric population: a regional seroepidemiological study 63
Evaluating the effect of targeted strategies as control tools for hypervirulent meningococcal C outbreaks: a case study from Tuscany, Italy, 2015 to 2016 63
Estimates of the reproductive numbers and demographic reconstruction of outbreak associated with C:P1.5 – 1,10 – 8:F3 – 6:ST – 11(cc11) Neisseria meningitidis strains 62
Chikungunya fever in Africa: a systematic review 62
Sex differences in clinical phenotype and transitions of care among individuals dying of COVID-19 in Italy 62
Temporal variations in excess mortality during phase 1 and phase 2 of the covid-19 epidemic in italy 61
Vaccinations in migrants and refugees: a challenge for European health systems. A systematic review of current scientific evidence. 61
Survival After AIDS Diagnosis in Italy, 1999-2006: A Population-Based Study 61
Effectiveness of Vaccination against SARS-CoV-2 Infection in the Pre-Delta Era: A Systematic Review and Meta-Analysis 61
Phylogeography and epidemiological history of West Nile virus genotype 1a in Europe and the Mediterranean basin 60
Reactive vaccination as control strategy for an outbreak of invasive meningococcal disease caused by Neisseria meningitidis C:P1.5-1,10-8:F3-6:ST-11(cc11), Bergamo province, Italy, December 2019 to January 2020 60
Continuous increase in HIV-1 incidence after the year 2000 among men who have sex with men in Rome: insights from a 25-year retrospective cohort study 59
Epidemiological characteristics of COVID-19 cases and estimates of the reproductive numbers 1 month into the epidemic, Italy, 28 January to 31 March 2020 59
Durability of neutralizing antibodies against yellow fever virus after vaccination in healthy adults 59
Long Covid: where we stand and challenges ahead 59
Primary prevention of congenital anomalies: Special focus on environmental chemicals and other toxicants, maternal health and health services and infectious diseases 58
Health and Climate Change: Science calls for global action 58
Risk behaviour and HTLV-1 seropositivity in injecting drug users 58
Imported and indigenous cases of invasive meningocococcal disease W:P1.5,2:F1-1: ST-11 in migrants’ reception centers. Italy, June-November 2014 57
Human mpox: global trends, molecular epidemiology and options for vaccination 57
Evolution of SARS-CoV-2 IgG Seroprevalence in Children and Factors Associated with Seroconversion: Results from a Multiple Time-Points Study in Friuli-Venezia Giulia Region, Italy 57
The effect of COVID-19 vaccination in Italy and perspectives for living with the virus 57
Variable Impact on Mortality of AIDS-Defining Events Diagnosed during Combination Antiretroviral Therapy: Not All AIDS-Defining Conditions Are Created Equal 57
Multiplex real-time reverse-transcription polymerase chain reaction assays for diagnostic testing of severe acute respiratory syndrome coronavirus 2 and seasonal influenza viruses: A challenge of the phase 3 pandemic setting 57
HPV Vaccination during the COVID-19 Pandemic in Italy: Opportunity Loss or Incremental Cost 56
Detection of a chikungunya outbreak in central Italy, August to September 2017 56
From mass vaccination to personalized vaccinology? The COVID-19 case. Commentary 55
Omicron variant evolution on vaccines and monoclonal antibodies 55
AREA TEMATICA: INFEZIONI EMERGENTI Il protocollo dell'Azienda Ospedaliero Universitaria Careggi, Firenze per la gestione delle donne in gravidanza esposte a rischio di infezione da Zika virus: report sui primi 9 mesi di attività 55
Impact of a nationwide lockdown on SARS-CoV-2 transmissibility, Italy 55
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 55
Co-circulation of SARS-CoV-2 Alpha and Gamma variants in Italy, February and March 2021 55
Evolution of Pathology Patterns in Persons Who Died From COVID-19 in Italy: A National Study Based on Death Certificates 54
Excess Mortality for Non-AIDS-Defining Cancers among People with AIDS 54
Risk prediction model of self-reported hypertension for telemedicine based on the sociodemographic, occupational and health-related characteristics of seafarers: A cross-sectional epidemiological study 54
Prevalence of IgM and IgG antibodies to West Nile virus among blood donors in an affected area of north-eastern Italy, summer 2009 54
Clinical Characteristics of Hospitalized Individuals Dying with COVID-19 by Age Group in Italy 54
Comorbidity status of deceased COVID-19 in-patients in Italy 53
TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies 53
The Italian 2017 outbreak chikungunya virus belongs to an emerging aedes albopictus-adapted virus cluster introduced from the Indian subcontinent 53
Totale 7.391
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.494
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.494
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226 0 0 0 1 0 0 3 2 0 0 0 0
2022/202346 17 11 2 0 2 5 4 4 1 0 0 0
2023/2024896 0 0 9 8 3 3 0 212 361 35 52 213
2024/20254.159 550 96 43 124 133 350 463 335 721 701 323 320
2025/202611.813 977 1.067 611 1.361 914 389 1.989 819 3.263 423 0 0
Totale 16.924